Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 07, 2023

SELL
$7.35 - $13.21 $361,009 - $648,835
-49,117 Reduced 44.04%
62,403 $458,000
Q1 2023

Apr 19, 2023

SELL
$7.79 - $16.29 $38,085 - $79,641
-4,889 Reduced 4.2%
111,520 $1.16 Million
Q4 2022

Feb 08, 2023

BUY
$11.0 - $21.45 $28,325 - $55,233
2,575 Added 2.26%
116,409 $1.37 Million
Q3 2022

Oct 19, 2022

SELL
$20.09 - $35.8 $11,732 - $20,907
-584 Reduced 0.51%
113,834 $2.43 Million
Q2 2022

Aug 09, 2022

SELL
$27.42 - $43.63 $24,705 - $39,310
-901 Reduced 0.78%
114,418 $3.47 Million
Q1 2022

Apr 11, 2022

BUY
$36.48 - $52.22 $57,565 - $82,403
1,578 Added 1.39%
115,319 $4.82 Million
Q4 2021

Jan 20, 2022

BUY
$33.11 - $55.01 $45,261 - $75,198
1,367 Added 1.22%
113,741 $5.15 Million
Q3 2021

Nov 01, 2021

SELL
$50.07 - $66.05 $5.63 Million - $7.42 Million
-112,374 Reduced 50.0%
112,374 $5.86 Million
Q3 2021

Nov 01, 2021

BUY
$50.07 - $66.05 $5.69 Million - $7.5 Million
113,610 Added 102.22%
224,748 $11.3 Million
Q2 2021

Jul 16, 2021

BUY
$56.61 - $80.46 $537,455 - $763,887
9,494 Added 9.34%
111,138 $7 Million
Q1 2021

May 17, 2021

SELL
$86.23 - $125.19 $176,599 - $256,389
-2,048 Reduced 1.98%
101,644 $9.38 Million
Q4 2020

Feb 12, 2021

SELL
$79.17 - $111.47 $181,220 - $255,154
-2,289 Reduced 2.16%
103,692 $9.29 Million
Q3 2020

Nov 09, 2020

SELL
$81.91 - $134.94 $8.53 Million - $14.1 Million
-104,145 Reduced 49.56%
105,981 $11.1 Million
Q2 2020

Aug 13, 2020

BUY
$54.33 - $89.52 $5.72 Million - $9.42 Million
105,251 Added 100.36%
210,126 $16.6 Million
Q1 2020

May 15, 2020

BUY
$49.34 - $68.76 $218,970 - $305,156
4,438 Added 4.42%
104,875 $5.76 Million
Q4 2019

Feb 11, 2020

BUY
$51.21 - $59.06 $1.53 Million - $1.76 Million
29,883 Added 42.35%
100,437 $5.5 Million
Q3 2019

Nov 13, 2019

BUY
$40.6 - $57.2 $20,300 - $28,600
500 Added 0.71%
70,554 $3.61 Million
Q2 2019

Aug 14, 2019

SELL
$39.92 - $53.86 $2.98 Million - $4.02 Million
-74,574 Reduced 51.56%
70,054 $3.39 Million
Q1 2019

May 20, 2019

BUY
$48.23 - $66.16 $159,544 - $218,857
3,308 Added 2.34%
144,628 $7.31 Million
Q4 2018

Feb 14, 2019

SELL
$55.63 - $73.24 $180,574 - $237,737
-3,246 Reduced 2.25%
141,320 $8.38 Million
Q3 2018

Nov 14, 2018

SELL
$52.05 - $66.51 $802,038 - $1.02 Million
-15,409 Reduced 9.63%
144,566 $9.52 Million
Q2 2018

Aug 13, 2018

BUY
$48.33 - $55.64 $2.57 Million - $2.96 Million
53,114 Added 49.7%
159,975 $8.08 Million
Q1 2018

May 14, 2018

BUY
$44.44 - $54.39 $2.19 Million - $2.67 Million
49,170 Added 85.23%
106,861 $5.63 Million
Q4 2017

Feb 12, 2018

SELL
$37.77 - $47.75 $87,437 - $110,541
-2,315 Reduced 3.86%
57,691 $2.68 Million
Q3 2017

Nov 09, 2017

BUY
$34.14 - $40.45 $2.05 Million - $2.43 Million
60,006
60,006 $2.43 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $438M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Nordea Investment Management Ab Portfolio

Follow Nordea Investment Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.